Zelenskyy rejects Putin's invite to Moscow and offers to talk in Kyiv
ADVERTISEMENT
ADVERTISEMENT
More about this topic
French minister says block to Sanofi deal is still 'on the table'
The potential sale of Opella, which produces Doliprane painkillers, is causing a headache in France.
US private equity firm set to win Sanofi's consumer health division
The proposed offer from Clayton, Dubilier & Rice (CD&R) would mean the sale of a 50% stake in Opella, which makes over-the-counter medicine such as Doliprane and Allegra.
Sanofi eyes €1.3 billion investment in insulin drug plant in Germany
Other healthcare companies such as Daiichi Sankyo have also announced investments in Germany recently, in a positive sign for the ruling coalition government.
Markets' week ahead: Lagarde speech and OPEC+ meeting in focus
European stocks started the week on a slightly gloomy note as investors looked forward to key economic data and speeches.
ADVERTISEMENT
Sanofi targeted in French price manipulation probe
French prosecutors say they have launched an investigation into Sanofi over allegations the pharmaceutical giant spread false information and manipulated the price of its Dupixent drug.
French drugmaker Sanofi halts development of its mRNA COVID vaccine
The pharmaceutical giant is worried its vaccine will be too late in reaching the market.
Sanofi/GSK launch Phase III trial of COVID-19 vaccine
The two companies will test their vaccine's efficacy against variants and when used as a second dose following a first injection with another vaccine.
French company Sanofi reports positive results from vaccine trial
The drugmaker reported good results from a phase 2 clinical trial of its coronavirus vaccine candidate, which has been hit by several months of delays.
France's Sanofi to produce millions of Johnson & Johnson COVID-19 jabs
Sanofi is to produce as many as 12 million doses a month of the Johnson & Johnson vaccine once approved. It has also agreed to manufacture 125 million doses of the Pfizer/BioNTech jab.
GSK-Sanofi says its COVID-19 vaccine won't be ready until late 2021
The companies said in a statement that "insufficient response in older adults demonstrates the need to refine concentration of antigen in order to provide high-level response across all age groups."
Sanofi being investigated for manslaughter over epilepsy drug Depakine
The firm is accused of being late to reveal the risk the medication poses to pregnant women.
French pharma giant irks Paris with US first for vaccine comment
Edouard Philippe, France's prime minister, said "equal access for everyone to the vaccine is not negotiable". It came after French pharma giant Sanofi suggested the US would be first in line for any cure.
Pharma giants GSK and Sanofi team up to find coronavirus vaccine
The pharma giants are hoping their scale will allow them to make a vaccine widely available by the second half of 2021.
Sanofi and Verily pair up to improve diabetes treatment
French drugmaker Sanofi and the US firm Verily are to invest around $500 million (445 million euros) in a joint venture to help people with diabetes.
Sanofi earnings to be 'stable' despite declining sales
French drugmaker Sanofi has pledged its 2016 earnings will be stable despite declining sales of diabetes and cancer treatments.